Thursday, January 23, 2014

Prostate Cancer Multidisciplinary Clinic

Multidisciplinary clinics are a relatively new trend in medicine.  The clinics offer patients the opportunity to meet, on the same day, experts from a number of fields within medicine and surgery.  For patients with cancer, this often is an opportunity to have records reviewed by expert pathologists and radiologists and to meet with a surgeon, radiation oncologist and medical oncologist in the same setting.  It prevents the patient from having to schedule multiple appointments with multiple experts in the field, creates a forum for conversation between experts in a variety of fields (rather than relying on interdepartmental consultations and discussions) and, in doing so, can streamline care.  For prostate cancer, multidisciplinary clinics from around the country demonstrate improved compliance with national guidelines, excellent oncologic outcomes and high patient satisfaction. [1,2]

Edward M. Schaeffer, MD, PhD
The Prostate Cancer Multidisciplinary Consultation (PCMDC) at Johns Hopkins has been offering this service since 2008.  Over the past 5 years, over 1,000 men with prostate cancer have been seen in the PCMDC.  Nearly 60% stay at Hopkins for their treatment: approximately 25% elect surgery, 25% radiation therapy, 10% active surveillance and 5% androgen deprivation treatment for advanced cancer.  All medical records are obtained, collated and reviewed by our experts prior to the PCMDC clinic appointment.  All prostate cancer slides obtained from the biopsy are reviewed by our expert urological pathologists and any imaging is reviewed by dedicated genitourinary radiologists.  A panel including these pathologists, radiologists, urologic oncology surgeons, radiation and medical oncologists then meet to review a patient's case.

Debasish Sundi, MD
Often changes are made, diagnoses can be adjusted and management options tweaked to best fit that patient's needs.  Under the tutelage of Edward M. Schaeffer, Associate Professor of Urology, Oncology and Pathology, and Co-Director of the PCMDC; Debasish Sundi (a senior resident at the Brady) will present data at American Society for Clinical Oncology (ASCO) Genitourinary Cancers Symposium demonstrating that nearly 30% of patients who present to the PCMDC will have a change in their risk category or stage.  For example, 3% of men were down classified to very -low risk prostate cancer and became eligible for active surveillance; 6% of men were upstaged to metastatic disease and had systemic therapy initiated rather than undergoing localized treatment. [3]

In addition, the PCMDC offers a unique opportunity for research.  For instance, many patients speak favorably about their experience at PCMDC, however little data exists validating these perceptions.  Over the next several months, we will be evaluating the patient-centered experience at the Johns Hopkins PCMDC by prospectively evaluating quality of life, satisfaction with care, and illness uncertainty among patients coping with a new diagnosis of prostate cancer.  The study is conducted entirely online and is administered through the NIH-funded tool for online clinical research: Assessment Center (www.assessmentventer.net). Patients complete online questionnaires before and after their clinic appointment and can access their personalized study webpage from their personal computers, tablets, or smart phones.  By focusing on patient-reported outcomes, our goal is to show a positive impact of multidisciplinary cancer care on the quality of life of men with newly diagnosed prostate cancer.  In addition, research opportunities exist to track cancer and functional outcomes following surgery and radiation treatments.  Novel therapies including gene-based vaccinations are offered to appropriate candidate patients.  Patients with advanced malignancies who have failed traditional therapies are offered the newest and latest options from Johns Hopkins experts.

If you are a patient with prostate cancer who would like a second opinion, or if you are a physician with a patient who you would like seen at PCMDC please call 410-955-6100.

1. Aizer AA, Paly JJ, Zietman AL, et al. Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer.  J Clin Oncol. 2012 Sep 1;30(25):3071-6. doi: 10.1200/JCO.2012.42.8466. Epub 2012 Jul 30.






  • 2.  Gomella LG
  • Lin J
  • Hoffman-Censits J
  • et al. 
  • Enhancing prostate cancer care through the multidisciplinary clinic approach: A 15-year experienceJ Oncol Pract 2010 6:e5e10.

    3. Sundi D, Cohen JE, Cole AP, Neuman BP, Cooper J, Faisal FA, Raben MG, Song DY, Drake CG, Netto GJ, Macura KJ, DeWeese TL, Partin AW, Bivalacqua TJ, Ross AE, Schaeffer EM. Multidisciplinary clinic evaluation changes prostate cancer stage and risk stratification.  To be presented at GU-ASCO, January 30-February 1, 2014; San Francisco, California.

    2 comments:

    1. I have being on blog Sites for a while now and today I felt like I should share my story because I was a victim too. I had HIV for 6 years and i never thought I would ever get a cure I had and this made it impossible for me to get married to the man I was supposed to get married to even after 2 years of relationship he broke up with me when he finds out I was HIV positive. So I got to know about Dr. Itua on Blog Site who treated someone and the person shared a story of how she got a cured and let her contact details, I contacted Dr. Itua and he actually confirmed it and I decided to give a try too and use his herbal medicine that was how my burden ended completely. My son will be 2 soon and I am grateful to God and thankful to his medicine too.Dr Itua Can As Well Cure The Following Disease…Alzheimer’s disease,Bechet’s disease,Crohn’s disease,Parkinson's disease,Schizophrenia,Lung Cancer,Breast Cancer,Colo-Rectal Cancer,Blood Cancer,Prostate Cancer,siva.Fatal Familial Insomnia Factor V Leiden Mutation ,Epilepsy Dupuytren's disease,Desmoplastic small-round-cell tumor Diabetes ,Coeliac disease,Creutzfeldt–Jakob disease,Cerebral Amyloid Angiopathy, Ataxia,Arthritis,Amyotrophic Lateral Scoliosis,Fibromyalgia,Fluoroquinolone Toxicity
      Syndrome Fibrodysplasia Ossificans ProgresSclerosis,Seizures,Alzheimer's disease,Adrenocortical carcinoma.Asthma,Allergic diseases.Hiv_ Aids,Herpe ,Copd,Glaucoma., Cataracts,Macular degeneration,Cardiovascular disease,Lung disease.Enlarged prostate,Osteoporosis.Alzheimer's disease,
      Dementia.Lupus.
      ,Cushing’s disease,Heart failure,Multiple Sclerosis,Hypertension,Colo_Rectal Cancer,Lyme Disease,Blood Cancer,Brain Cancer,Breast Cancer,Lung Cancer,Kidney Cancer, HIV, Herpes,Hepatitis B, Liver Inflammatory,Diabetes,Fibroid, Get Your Ex Back, If you have (A just reach him on drituaherbalcenter@gmail.com Or Whatsapp Number.+2348149277967)He can also advise you on how to handle some marital's issues. He's a good man. 

      ReplyDelete
    2. I was diagnosed as HEPATITIS B carrier in 2013 with fibrosis of the
      liver already present. I started on antiviral medications which
      reduced the viral load initially. After a couple of years the virus
      became resistant. I started on HEPATITIS B Herbal treatment from
      ULTIMATE LIFE CLINIC (www.ultimatelifeclinic.com) in March, 2020. Their
      treatment totally reversed the virus. I did another blood test after
      the 6 months long treatment and tested negative to the virus. Amazing
      treatment! This treatment is a breakthrough for all HBV carriers.

      ReplyDelete